Monday, December 1, 2008

An awful selloff to start the week

News that we've been in recession for almost a year whacked the markets today, with the Nasdaq down almost 9%. Many of my holdings were down that much or more. There was a nice piece of news out of Regulus, however, regarding pre-clinical microRNA efficacy data. Regulus is co-owned by Alnylam (12.9% of portfolio) and Isis Pharmaceuticals (calls 4.8% of portfolio), and since I own both, I hope they progress steadily. I have yet to listen to the conference call replay.